JP2002523511A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002523511A5 JP2002523511A5 JP2000567536A JP2000567536A JP2002523511A5 JP 2002523511 A5 JP2002523511 A5 JP 2002523511A5 JP 2000567536 A JP2000567536 A JP 2000567536A JP 2000567536 A JP2000567536 A JP 2000567536A JP 2002523511 A5 JP2002523511 A5 JP 2002523511A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- pyrimidine
- methylpropyl
- thieno
- dione
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 description 28
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 23
- -1 amino, nitro, cyano, trifluoromethoxy, phenoxy Chemical group 0.000 description 19
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 10
- 150000003839 salts Chemical class 0.000 description 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 9
- 239000012453 solvate Substances 0.000 description 9
- 125000000217 alkyl group Chemical group 0.000 description 7
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 125000003545 alkoxy group Chemical group 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 5
- 125000001424 substituent group Chemical group 0.000 description 5
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 4
- 125000004076 pyridyl group Chemical group 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 125000004430 oxygen atom Chemical group O* 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 229910052717 sulfur Chemical group 0.000 description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 2
- NKAMAKVCUVIVTK-UHFFFAOYSA-N 1-(cyclopropylmethyl)-3-methyl-6-[(1-methylbenzimidazol-2-yl)methyl]thieno[2,3-d]pyrimidine-2,4-dione Chemical compound N=1C2=CC=CC=C2N(C)C=1CC(S1)=CC(C(N(C)C2=O)=O)=C1N2CC1CC1 NKAMAKVCUVIVTK-UHFFFAOYSA-N 0.000 description 2
- GJQRXSNYCXFEJD-UHFFFAOYSA-N 3-methyl-1-(2-methylpropyl)-6-(1,3-thiazol-2-ylmethyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CC1=NC=CS1 GJQRXSNYCXFEJD-UHFFFAOYSA-N 0.000 description 2
- XQRUPBHBUFCSNE-UHFFFAOYSA-N 3-methyl-1-(2-methylpropyl)-6-(1h-pyrrolo[2,3-b]pyridin-3-ylmethyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=CC=C2C(CC=3SC=4N(C(N(C)C(=O)C=4C=3)=O)CC(C)C)=CNC2=N1 XQRUPBHBUFCSNE-UHFFFAOYSA-N 0.000 description 2
- XQGBWCSNZSTOGH-UHFFFAOYSA-N 3-methyl-1-(2-methylpropyl)-6-(pyridin-2-ylmethyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CC1=CC=CC=N1 XQGBWCSNZSTOGH-UHFFFAOYSA-N 0.000 description 2
- DGXSDNVECZHQAZ-UHFFFAOYSA-N 3-methyl-1-(2-methylpropyl)-6-(pyridin-3-ylmethyl)-5-thiophen-2-ylsulfanylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C=1C=CSC=1SC=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CC1=CC=CN=C1 DGXSDNVECZHQAZ-UHFFFAOYSA-N 0.000 description 2
- IMLLAPNOOLJMMH-UHFFFAOYSA-N 3-methyl-1-(2-methylpropyl)-6-(pyridin-3-ylmethyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CC1=CC=CN=C1 IMLLAPNOOLJMMH-UHFFFAOYSA-N 0.000 description 2
- SUQLZAAGFNNDBQ-UHFFFAOYSA-N 3-methyl-1-(2-methylpropyl)-6-(pyridin-4-ylmethyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CC1=CC=NC=C1 SUQLZAAGFNNDBQ-UHFFFAOYSA-N 0.000 description 2
- CRWMCZHHOIGMNV-UHFFFAOYSA-N 3-methyl-1-(2-methylpropyl)-6-(pyridine-3-carbonyl)-5-thiophen-2-ylsulfanylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C=1C=CSC=1SC=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1C(=O)C1=CC=CN=C1 CRWMCZHHOIGMNV-UHFFFAOYSA-N 0.000 description 2
- FPCROBDZIRUNIV-UHFFFAOYSA-N 3-methyl-1-(2-methylpropyl)-6-(thiophen-2-ylmethyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CC1=CC=CS1 FPCROBDZIRUNIV-UHFFFAOYSA-N 0.000 description 2
- FVELFONZJZPXTG-UHFFFAOYSA-N 3-methyl-1-(2-methylpropyl)-6-[(3-oxo-1,2-benzothiazol-2-yl)methyl]-5-propan-2-ylsulfanylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound S1C2=CC=CC=C2C(=O)N1CC(S1)=C(SC(C)C)C2=C1N(CC(C)C)C(=O)N(C)C2=O FVELFONZJZPXTG-UHFFFAOYSA-N 0.000 description 2
- WBAKOAPFWILXJX-UHFFFAOYSA-N 3-methyl-6-(1-methylbenzimidazole-2-carbonyl)-1-(2-methylpropyl)-5-propan-2-ylsulfanylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=CC=C2N(C)C(C(=O)C=3SC=4N(C(N(C)C(=O)C=4C=3SC(C)C)=O)CC(C)C)=NC2=C1 WBAKOAPFWILXJX-UHFFFAOYSA-N 0.000 description 2
- DSQHABJZILXDLV-UHFFFAOYSA-N 3-methyl-6-[(1-methylbenzimidazol-2-yl)methyl]-1-(2-methylpropyl)-5-propan-2-ylsulfanylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=CC=C2N(C)C(CC=3SC=4N(C(N(C)C(=O)C=4C=3SC(C)C)=O)CC(C)C)=NC2=C1 DSQHABJZILXDLV-UHFFFAOYSA-N 0.000 description 2
- LITLXRLYLVSWBD-UHFFFAOYSA-N 3-methyl-6-[(1-methylbenzimidazol-2-yl)methyl]-1-(2-methylpropyl)-5-propan-2-ylsulfonylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=CC=C2N(C)C(CC=3SC=4N(C(N(C)C(=O)C=4C=3S(=O)(=O)C(C)C)=O)CC(C)C)=NC2=C1 LITLXRLYLVSWBD-UHFFFAOYSA-N 0.000 description 2
- AMUJWWSZSRTUKN-UHFFFAOYSA-N 5-(3-hydroxypropoxy)-3-methyl-1-(2-methylpropyl)-6-(pyridin-3-ylmethyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound OCCCOC=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CC1=CC=CN=C1 AMUJWWSZSRTUKN-UHFFFAOYSA-N 0.000 description 2
- NSJKRGJIUCTXFM-UHFFFAOYSA-N 5-(3-hydroxypropylsulfanyl)-3-methyl-1-(2-methylpropyl)-6-(pyridin-3-ylmethyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound OCCCSC=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CC1=CC=CN=C1 NSJKRGJIUCTXFM-UHFFFAOYSA-N 0.000 description 2
- KJDSEKFFXGDYOD-UHFFFAOYSA-N 5-(3-hydroxypropylsulfanyl)-3-methyl-1-(2-methylpropyl)-6-(pyridine-3-carbonyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound OCCCSC=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1C(=O)C1=CC=CN=C1 KJDSEKFFXGDYOD-UHFFFAOYSA-N 0.000 description 2
- GMAOFLBDXUFBSG-UHFFFAOYSA-N 5-(3-hydroxypropylsulfanyl)-6-[hydroxy(pyridin-3-yl)methyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound OCCCSC=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1C(O)C1=CC=CN=C1 GMAOFLBDXUFBSG-UHFFFAOYSA-N 0.000 description 2
- SCWAQHDJVTWJEC-UHFFFAOYSA-N 5-(azetidine-1-carbonyl)-1-(cyclopropylmethyl)-3-methyl-6-[(1-methylbenzimidazol-2-yl)methyl]thieno[2,3-d]pyrimidine-2,4-dione Chemical compound N=1C2=CC=CC=C2N(C)C=1CC(=C(C=1C(=O)N(C)C2=O)C(=O)N3CCC3)SC=1N2CC1CC1 SCWAQHDJVTWJEC-UHFFFAOYSA-N 0.000 description 2
- NWMHICYOEMTIFL-OAHLLOKOSA-N 5-[(3r)-3-hydroxypyrrolidin-1-yl]sulfonyl-3-methyl-1-(2-methylpropyl)-6-(pyridin-3-ylmethyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C([C@H](O)CC1)N1S(=O)(=O)C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CC1=CC=CN=C1 NWMHICYOEMTIFL-OAHLLOKOSA-N 0.000 description 2
- UQVFEKVXIUKTIA-UHFFFAOYSA-N 6-(benzimidazol-1-ylmethyl)-1-(cyclopropylmethyl)-3-methylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2SC(CN3C4=CC=CC=C4N=C3)=CC=2C(=O)N(C)C(=O)N1CC1CC1 UQVFEKVXIUKTIA-UHFFFAOYSA-N 0.000 description 2
- DAZOSFZMQSTKRC-UHFFFAOYSA-N 6-(benzimidazol-1-ylmethyl)-3-methyl-1-(2-methylpropyl)-5-(pyrrolidine-1-carbonyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC(CN2C3=CC=CC=C3N=C2)=C1C(=O)N1CCCC1 DAZOSFZMQSTKRC-UHFFFAOYSA-N 0.000 description 2
- MQCHNBJYTPUQRP-UHFFFAOYSA-N 6-(benzimidazol-1-ylmethyl)-3-methyl-1-(2-methylpropyl)-5-thiophen-2-ylsulfanylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC(CN2C3=CC=CC=C3N=C2)=C1SC1=CC=CS1 MQCHNBJYTPUQRP-UHFFFAOYSA-N 0.000 description 2
- ARZUNQNWVZXAOQ-UHFFFAOYSA-N 6-(benzimidazol-1-ylmethyl)-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=NC2=CC=CC=C2N1CC(S1)=CC2=C1N(CC(C)C)C(=O)N(C)C2=O ARZUNQNWVZXAOQ-UHFFFAOYSA-N 0.000 description 2
- LKJZWOJOQXWWMP-UHFFFAOYSA-N 6-(benzimidazol-1-ylmethyl)-3-methyl-1-propan-2-ylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=NC2=CC=CC=C2N1CC(S1)=CC2=C1N(C(C)C)C(=O)N(C)C2=O LKJZWOJOQXWWMP-UHFFFAOYSA-N 0.000 description 2
- XFWKMDVLXOAROG-UHFFFAOYSA-N 6-(benzotriazol-1-ylmethyl)-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound N1=NC2=CC=CC=C2N1CC(S1)=CC2=C1N(CC(C)C)C(=O)N(C)C2=O XFWKMDVLXOAROG-UHFFFAOYSA-N 0.000 description 2
- HPVJZAYZQRPTDJ-UHFFFAOYSA-N 6-(benzotriazol-2-ylmethyl)-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound N1=C2C=CC=CC2=NN1CC(S1)=CC2=C1N(CC(C)C)C(=O)N(C)C2=O HPVJZAYZQRPTDJ-UHFFFAOYSA-N 0.000 description 2
- HSCFYYZKGKEYCH-UHFFFAOYSA-N 6-(indazol-1-ylmethyl)-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound N1=CC2=CC=CC=C2N1CC(S1)=CC2=C1N(CC(C)C)C(=O)N(C)C2=O HSCFYYZKGKEYCH-UHFFFAOYSA-N 0.000 description 2
- SJULOZMZRAUZMG-UHFFFAOYSA-N 6-(indazol-2-ylmethyl)-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=C2C=CC=CC2=NN1CC(S1)=CC2=C1N(CC(C)C)C(=O)N(C)C2=O SJULOZMZRAUZMG-UHFFFAOYSA-N 0.000 description 2
- QYOXPODCRHMTOK-UHFFFAOYSA-N 6-[(1,3-dioxoisoindol-2-yl)methyl]-3-methyl-1-(2-methylpropyl)-5-thiophen-2-ylsulfanylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC(CN2C(C3=CC=CC=C3C2=O)=O)=C1SC1=CC=CS1 QYOXPODCRHMTOK-UHFFFAOYSA-N 0.000 description 2
- CARZRMQRFMKZSE-UHFFFAOYSA-N 6-[(1,4-dioxo-3h-phthalazin-2-yl)methyl]-3-methyl-1-(2-methylpropyl)-5-propan-2-ylsulfanylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound N1C(=O)C2=CC=CC=C2C(=O)N1CC(S1)=C(SC(C)C)C2=C1N(CC(C)C)C(=O)N(C)C2=O CARZRMQRFMKZSE-UHFFFAOYSA-N 0.000 description 2
- LODJBUNSQMNQBS-UHFFFAOYSA-N 6-[(2-chlorobenzimidazol-1-yl)methyl]-3-methyl-1-(2-methylpropyl)-5-thiophen-2-ylsulfanylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC(CN2C3=CC=CC=C3N=C2Cl)=C1SC1=CC=CS1 LODJBUNSQMNQBS-UHFFFAOYSA-N 0.000 description 2
- YAAMAAXAZWGTFW-UHFFFAOYSA-N 6-[(4-chloro-1-methylpyrazol-3-yl)-hydroxymethyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1C(O)C1=NN(C)C=C1Cl YAAMAAXAZWGTFW-UHFFFAOYSA-N 0.000 description 2
- DQVOETUVDDMBAJ-UHFFFAOYSA-N 6-[(4-chloro-1-methylpyrazol-3-yl)methyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CC1=NN(C)C=C1Cl DQVOETUVDDMBAJ-UHFFFAOYSA-N 0.000 description 2
- AYUGUDMLFQMCEC-UHFFFAOYSA-N 6-[(5-chlorothiophen-2-yl)-hydroxymethyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1C(O)C1=CC=C(Cl)S1 AYUGUDMLFQMCEC-UHFFFAOYSA-N 0.000 description 2
- FOGCVSIRJSFWJC-UHFFFAOYSA-N 6-[(5-chlorothiophen-2-yl)methyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CC1=CC=C(Cl)S1 FOGCVSIRJSFWJC-UHFFFAOYSA-N 0.000 description 2
- WEIQMEUHRGBRFZ-UHFFFAOYSA-N 6-[hydroxy(1,3-thiazol-2-yl)methyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1C(O)C1=NC=CS1 WEIQMEUHRGBRFZ-UHFFFAOYSA-N 0.000 description 2
- VCBYSTZNJAZSMW-UHFFFAOYSA-N 6-[hydroxy(pyridin-2-yl)methyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1C(O)C1=CC=CC=N1 VCBYSTZNJAZSMW-UHFFFAOYSA-N 0.000 description 2
- LQTUQKQSHVWMDW-UHFFFAOYSA-N 6-[hydroxy(pyridin-3-yl)methyl]-3-methyl-1-(2-methylpropyl)-5-propan-2-ylsulfanylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound CC(C)SC=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1C(O)C1=CC=CN=C1 LQTUQKQSHVWMDW-UHFFFAOYSA-N 0.000 description 2
- BCZHYOXHQNCJEP-UHFFFAOYSA-N 6-[hydroxy(pyridin-3-yl)methyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1C(O)C1=CC=CN=C1 BCZHYOXHQNCJEP-UHFFFAOYSA-N 0.000 description 2
- IMGVYVFMNBEGTO-UHFFFAOYSA-N 6-[hydroxy(pyridin-4-yl)methyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1C(O)C1=CC=NC=C1 IMGVYVFMNBEGTO-UHFFFAOYSA-N 0.000 description 2
- NTPNEWWRXUIHCB-UHFFFAOYSA-N 6-[hydroxy(thiophen-2-yl)methyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1C(O)C1=CC=CS1 NTPNEWWRXUIHCB-UHFFFAOYSA-N 0.000 description 2
- HSVZZBLWYSPELB-UHFFFAOYSA-N 6-[hydroxy(thiophen-3-yl)methyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1C(O)C=1C=CSC=1 HSVZZBLWYSPELB-UHFFFAOYSA-N 0.000 description 2
- UMDLABDUJBFKRM-UHFFFAOYSA-N 6-[hydroxy-(1-methylbenzimidazol-2-yl)methyl]-3-methyl-1-(2-methylpropyl)-5-propan-2-ylsulfanylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=CC=C2N(C)C(C(O)C=3SC=4N(C(N(C)C(=O)C=4C=3SC(C)C)=O)CC(C)C)=NC2=C1 UMDLABDUJBFKRM-UHFFFAOYSA-N 0.000 description 2
- HIGFITSDKNNWTJ-UHFFFAOYSA-N 6-[hydroxy-(1-methylbenzimidazol-2-yl)methyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=CC=C2N(C)C(C(O)C=3SC=4N(C(N(C)C(=O)C=4C=3)=O)CC(C)C)=NC2=C1 HIGFITSDKNNWTJ-UHFFFAOYSA-N 0.000 description 2
- JCNVVNANFIZEMZ-UHFFFAOYSA-N 6-[hydroxy-(1-methylbenzimidazol-2-yl)methyl]-3-methyl-1-propan-2-ylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=CC=C2N(C)C(C(O)C=3SC=4N(C(N(C)C(=O)C=4C=3)=O)C(C)C)=NC2=C1 JCNVVNANFIZEMZ-UHFFFAOYSA-N 0.000 description 2
- UHLNLJGYZGCXIZ-UHFFFAOYSA-N 6-[hydroxy-[6-(trifluoromethyl)pyridin-2-yl]methyl]-3-methyl-1-(2-methylpropyl)-5-thiophen-2-ylsulfanylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C=1C=CSC=1SC=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1C(O)C1=CC=CC(C(F)(F)F)=N1 UHLNLJGYZGCXIZ-UHFFFAOYSA-N 0.000 description 2
- 125000003830 C1- C4 alkylcarbonylamino group Chemical group 0.000 description 2
- ZJKGXLPYZUBLOI-UHFFFAOYSA-N C=1C=2C(=O)NC(=O)N(CC(C)C)C=2SC=1C(=O)C1=CC=CN=C1 Chemical compound C=1C=2C(=O)NC(=O)N(CC(C)C)C=2SC=1C(=O)C1=CC=CN=C1 ZJKGXLPYZUBLOI-UHFFFAOYSA-N 0.000 description 2
- XIPCEWGRKCZHJT-UHFFFAOYSA-N S1C(=NC2=C1C=CC=C2)C1=C(C2=C(N(C(N(C2=O)C)=O)CC(C)C)S1)C Chemical compound S1C(=NC2=C1C=CC=C2)C1=C(C2=C(N(C(N(C2=O)C)=O)CC(C)C)S1)C XIPCEWGRKCZHJT-UHFFFAOYSA-N 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 125000004190 benzothiazol-2-yl group Chemical group [H]C1=C([H])C([H])=C2N=C(*)SC2=C1[H] 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Chemical group 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Natural products C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- 125000004760 (C1-C4) alkylsulfonylamino group Chemical group 0.000 description 1
- 125000006555 (C3-C5) cycloalkyl group Chemical group 0.000 description 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 description 1
- MPWWUNWBNNDDBR-UHFFFAOYSA-N 1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound O=C1NC(=O)N(CC(C)C)C2=C1C=CS2 MPWWUNWBNNDDBR-UHFFFAOYSA-N 0.000 description 1
- IJOFJRNWCALZKL-UHFFFAOYSA-N 3-methyl-1-(2-methylpropyl)-6-(pyridin-3-ylmethyl)-5-pyrrolidin-1-ylsulfonylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1CCCN1S(=O)(=O)C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CC1=CC=CN=C1 IJOFJRNWCALZKL-UHFFFAOYSA-N 0.000 description 1
- FPEQZNUKJTYNCR-UHFFFAOYSA-N 6-(benzimidazol-1-ylmethyl)-3-methyl-1-(2-methylpropyl)-5-propan-2-ylsulfanylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=NC2=CC=CC=C2N1CC(S1)=C(SC(C)C)C2=C1N(CC(C)C)C(=O)N(C)C2=O FPEQZNUKJTYNCR-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- KPCZJLGGXRGYIE-UHFFFAOYSA-N [C]1=CC=CN=C1 Chemical group [C]1=CC=CN=C1 KPCZJLGGXRGYIE-UHFFFAOYSA-N 0.000 description 1
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- LVWZTYCIRDMTEY-UHFFFAOYSA-N metamizole Chemical compound O=C1C(N(CS(O)(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 LVWZTYCIRDMTEY-UHFFFAOYSA-N 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- ILVXOBCQQYKLDS-UHFFFAOYSA-N pyridine N-oxide Chemical compound [O-][N+]1=CC=CC=C1 ILVXOBCQQYKLDS-UHFFFAOYSA-N 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 239000011593 sulfur Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9802895-4 | 1998-08-28 | ||
| SE9802895 | 1998-08-28 | ||
| PCT/SE1999/001400 WO2000012514A1 (en) | 1998-08-28 | 1999-08-18 | Novel compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002523511A JP2002523511A (ja) | 2002-07-30 |
| JP2002523511A5 true JP2002523511A5 (https=) | 2006-10-05 |
Family
ID=20412397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000567536A Pending JP2002523511A (ja) | 1998-08-28 | 1999-08-18 | 新規化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6300334B1 (https=) |
| EP (1) | EP1107973B1 (https=) |
| JP (1) | JP2002523511A (https=) |
| AT (1) | ATE253580T1 (https=) |
| AU (1) | AU763758B2 (https=) |
| CA (1) | CA2339664A1 (https=) |
| DE (1) | DE69912618T2 (https=) |
| DK (1) | DK1107973T3 (https=) |
| ES (1) | ES2211161T3 (https=) |
| NZ (1) | NZ509809A (https=) |
| PT (1) | PT1107973E (https=) |
| WO (1) | WO2000012514A1 (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9801399D0 (sv) | 1998-04-21 | 1998-04-21 | Astra Pharma Prod | Method and apparatus for filling containers |
| EP1280806B1 (en) * | 2000-05-04 | 2004-08-04 | AstraZeneca AB | THIENO 2,3-d]PYRIMIDINEDIONES AND THEIR USE AS PHARMACEUTICALS |
| GB2361917A (en) * | 2000-05-04 | 2001-11-07 | Astrazeneca Ab | Novel thieno[2,3-d]pyrimidinediones |
| GB2363377B (en) * | 2000-06-14 | 2004-06-09 | Astrazeneca Ab | Novel thieno[2,3-d]pyrimidinediones and therapeutic uses thereof |
| EP1370562A1 (en) * | 2001-02-14 | 2003-12-17 | Warner-Lambert Company LLC | Thieno[2,3-d]pyrimidindione derivatives as matrix metalloproteinase inhibitors |
| GB0117583D0 (en) * | 2001-07-19 | 2001-09-12 | Astrazeneca Ab | Novel compounds |
| GB0118479D0 (en) * | 2001-07-28 | 2001-09-19 | Astrazeneca Ab | Novel compounds |
| MXPA05007495A (es) * | 2003-01-17 | 2005-09-21 | Astrazeneca Ab | Tienopiridazinonas y su uso en la modulacion de enfermedades autoinmunes. |
| SE0300120D0 (sv) * | 2003-01-17 | 2003-01-17 | Astrazeneca Ab | Novel compounds |
| SE0300119D0 (sv) * | 2003-01-17 | 2003-01-17 | Astrazeneca Ab | Novel compounds |
| CN1925855B (zh) | 2003-12-19 | 2010-06-16 | 普莱希科公司 | 开发Ret调节剂的化合物和方法 |
| US7498342B2 (en) | 2004-06-17 | 2009-03-03 | Plexxikon, Inc. | Compounds modulating c-kit activity |
| WO2006115509A2 (en) | 2004-06-24 | 2006-11-02 | Novartis Vaccines And Diagnostics Inc. | Small molecule immunopotentiators and assays for their detection |
| CA2644996A1 (en) * | 2006-03-02 | 2007-09-13 | Cv Therapeutics, Inc. | A2a adenosine receptor antagonists |
| WO2008063888A2 (en) | 2006-11-22 | 2008-05-29 | Plexxikon, Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
| WO2009012283A1 (en) | 2007-07-17 | 2009-01-22 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
| EP2411395B1 (en) * | 2009-03-23 | 2013-05-29 | Glenmark Pharmaceuticals S.A. | Furopyrimidinedione derivatives as trpa1 modulators |
| MY172424A (en) | 2009-04-03 | 2019-11-25 | Hoffmann La Roche | Propane- i-sulfonic acid {3- (4-chloro-phenyl)-1h-pyrrolo [2, 3-b] pyridine-3-carconyl] -2, 4-difluoro-phenyl} -amide compositions and uses thereof |
| CN106220623A (zh) | 2009-11-06 | 2016-12-14 | 普莱希科公司 | 用于激酶调节的化合物和方法及其适应症 |
| US9624213B2 (en) | 2011-02-07 | 2017-04-18 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
| AR085279A1 (es) | 2011-02-21 | 2013-09-18 | Plexxikon Inc | Formas solidas de {3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico |
| US9150570B2 (en) | 2012-05-31 | 2015-10-06 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
| KR20160065957A (ko) | 2013-10-07 | 2016-06-09 | 바이엘 파마 악티엔게젤샤프트 | 시클릭 티에노우라실-카르복스아미드 및 그의 용도 |
| UY36586A (es) * | 2015-03-26 | 2016-10-31 | Bayer Pharma AG | Heterociclilmetiltienouracilos y uso de los mismos |
| WO2018041771A1 (de) | 2016-09-02 | 2018-03-08 | Bayer Pharma Aktiengesellschaft | (1-methylcyclopropyl)methyl-substituierte thienouracile und ihre verwendung |
| CA3037642A1 (en) | 2016-09-23 | 2018-03-29 | Bayer Aktiengesellschaft | N 3 -cyclically substituted thienouraciles and use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01213284A (ja) * | 1988-02-22 | 1989-08-28 | Sankyo Co Ltd | チエノピリミジン−２，４−ジオン誘導体 |
| DD293824A5 (de) * | 1990-04-24 | 1991-09-12 | Karl-Marx-Universitaet Leipzig,De | Verfahren zur herstellung von 3-(mercaptoalkyl)=thieno/2,3-d/pyrimidin-2,4(1h,3h)-dionen |
| TW276256B (https=) * | 1993-08-26 | 1996-05-21 | Takeda Pharm Industry Co Ltd |
-
1999
- 1999-08-18 DE DE69912618T patent/DE69912618T2/de not_active Expired - Fee Related
- 1999-08-18 CA CA002339664A patent/CA2339664A1/en not_active Abandoned
- 1999-08-18 DK DK99944964T patent/DK1107973T3/da active
- 1999-08-18 US US09/402,837 patent/US6300334B1/en not_active Expired - Fee Related
- 1999-08-18 NZ NZ509809A patent/NZ509809A/xx unknown
- 1999-08-18 ES ES99944964T patent/ES2211161T3/es not_active Expired - Lifetime
- 1999-08-18 AT AT99944964T patent/ATE253580T1/de not_active IP Right Cessation
- 1999-08-18 WO PCT/SE1999/001400 patent/WO2000012514A1/en not_active Ceased
- 1999-08-18 AU AU57677/99A patent/AU763758B2/en not_active Ceased
- 1999-08-18 PT PT99944964T patent/PT1107973E/pt unknown
- 1999-08-18 EP EP99944964A patent/EP1107973B1/en not_active Expired - Lifetime
- 1999-08-18 JP JP2000567536A patent/JP2002523511A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002523511A5 (https=) | ||
| JP6507216B2 (ja) | ２−（モルホリン−４−イル）−１，７−ナフチリジン | |
| KR101178747B1 (ko) | 프로톤 펌프 저해제 | |
| KR100908155B1 (ko) | 히스타민 ｈ3 수용체 리간드로서 유용한테트라하이드로나프티리딘 유도체 | |
| AU2009292931B2 (en) | Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases | |
| KR101408561B1 (ko) | 산 분비 억제제로서 1-헤테로시클릴술포닐, 2-아미노메틸, 5-(헤테로-) 아릴 치환된 1-ｈ-피롤 유도체 | |
| KR100869393B1 (ko) | 단백질 키나제 억제제로서 피라졸-치환된 아미노헤테로아릴화합물 | |
| JP2010513304A5 (https=) | ||
| AU2004220382B2 (en) | Imidazol-4-yl-ethynyl-pyridine derivatives | |
| CN1960984B (zh) | 作为mglu5受体拮抗剂的吡啶-4-基-乙炔基-咪唑和吡唑 | |
| US20050020578A1 (en) | Sorbitol dehydrogenase inhibitors | |
| TW420669B (en) | Pyridine type thiazolidines | |
| AU2013286894A1 (en) | Heterocyclic modulators of lipid synthesis | |
| JP2019527731A (ja) | Ｈｂｖ感染の治療のための新規治療薬 | |
| JP2007529479A (ja) | マラリアの治療及び予防を意図する医薬品を調製するためのインダゾールカルボキサミド誘導体の使用 | |
| JP2010529991A5 (https=) | ||
| CA2351725A1 (en) | Substituted pyrazoles as p38 kinase inhibitors | |
| JP2013528591A5 (https=) | ||
| EP1957478A2 (en) | New compounds | |
| KR20140103286A (ko) | 인자 ＸＩａ 억제제로서 피리디논 및 피리미디논 유도체 | |
| TW201302730A (zh) | 吡唑化合物 | |
| AU2004309254A1 (en) | Amidopyrazole derivative | |
| AU2002247726C1 (en) | 2-Thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry | |
| CN110520422B (zh) | 新型吡啶酮羧酸衍生物或其盐 | |
| CN100572381C (zh) | 吡唑并二氮杂萘衍生物 |